12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TTI-1612: Phase I start

This month, Trillium will begin an open-label, single dose-ascending, Canadian Phase I trial in 28 patients....

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >